BackEpigenomics AG Overview

Epigenomics AG Current Cash

Latest current cash for ECX.F: $280K.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$277000.00
↓ 63.74% YoYΔ $-487000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Epigenomics AG Current Cash History

Loading

Epigenomics AG vs. peers: Current Cash Comparison

Loading

Epigenomics AG Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Epigenomics AG (ECX.F) FAQ

Epigenomics AG posts a current cash of $280K as of June 2026. That compares with $760K in the prior-year period — down 63.7% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Epigenomics AG's current cash was $760K. The latest reading is $280K — a 63.7% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Current Cash is one piece of Epigenomics AG's financial statement story. At $280K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for ECX.F's current cash usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Epigenomics AG's other metric pages and overview cover the third.